Behavioral Interventions Show Immediate Gains in Speech After Stroke, Review Finds

Behavioral interventions for post-stroke dysarthria appear to deliver immediate benefits to speech function, according to a systematic review and meta-analysis of randomized controlled trials published in BMC Neurology on 28 October 2026. The review found that these therapies improved activity-level outcomes and neuromuscular impairment in the short term, while evidence for longer-lasting effects remained inconclusive.

The authors of the review noted that the existing body of evidence on the efficacy of behavioral interventions for this condition had been limited, and their study aimed to systematically evaluate the effects of such interventions on dysarthric speech in patients with stroke.

The research team searched seven databases—Scopus, Web of Science, PubMed, EMBASE, the Cochrane Library, CINAHL and PsycINFO—for randomized controlled trials published from database inception to August 2026, using keywords related to stroke and dysarthria. The analysis ultimately included eight randomized controlled trials conducted between 2010 and 2026, covering a total of 407 patients.

Methodological quality was assessed using the Cochrane Risk-of-Bias tool 2.0, and the certainty of evidence for each outcome was evaluated using the GRADE approach. Of the eight trials, 62.5 percent—five out of eight—exhibited a low risk of bias, indicating that most of the included studies were judged methodologically sound.

For the meta-analysis, the researchers used the standardized mean difference with corresponding 95 percent confidence intervals as the effect size. In terms of immediate effects, behavioral interventions demonstrated greater improvements in activity than control groups, with a standardized mean difference of 0.42 (95 percent CI: 0.10–0.75; I2: 13 percent; Z = 2.54; P = 0.01). This outcome was rated as low-certainty evidence.

The interventions also showed greater immediate improvements in neuromuscular impairment, with a standardized mean difference of 0.47 (95 percent CI: 0.25–0.69; I2: 34 percent; Z = 4.24; P < 0.01). This finding was rated as moderate-certainty evidence. Sensitivity analyses confirmed the robustness of both findings, according to the review.

The authors concluded that behavioral interventions demonstrate promising immediate benefits on tongue and lip control and speech intelligibility in individuals with post-stroke dysarthria. These outcomes correspond to the neuromuscular and activity-level domains where the pooled results showed statistically significant short-term advantages over control conditions.

However, the picture was less clear for lasting effects. The review found that evidence regarding persistent effects of behavioral interventions on activity, neuromuscular impairment, and participation remained inconclusive, due to limited sample sizes and wide confidence intervals in the available trials.

Based on these findings, the authors called for large-scale randomized controlled trials with standardized outcome measures and extended follow-up periods. Such studies, they noted, are needed to evaluate whether behavioral interventions produce sustained effects over time and to strengthen the evidence base for clinical practice.

Subject of Research: Behavioral interventions for post-stroke dysarthria

Article Title: The effects of behavioral interventions for post-stroke dysarthria: a systematic review and meta-analysis of randomized controlled trials

Article References: Yuan, W., Ding, S., & Xu, Y. (2026). The effects of behavioral interventions for post-stroke dysarthria: a systematic review and meta-analysis of randomized controlled trials. BMC Neurology. https://doi.org/10.1186/s12883-026-05574-1

Image Credits: AI Generated

DOI: 10.1186/s12883-026-05574-1

Keywords: post-stroke dysarthria, behavioral interventions, systematic review, meta-analysis, randomized controlled trials, speech intelligibility, neuromuscular impairment, stroke rehabilitation, BMC Neurology, GRADE evidence, tongue and lip control, speech therapy